Brokerages Set The Beauty Health Company (NASDAQ:SKIN) PT at $2.02

Shares of The Beauty Health Company (NASDAQ:SKIN) have been given a consensus recommendation of “Hold” by the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $2.02.

Several research firms have recently issued reports on SKIN. Zacks Research upgraded Beauty Health from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. TD Cowen dropped their price objective on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. Canaccord Genuity Group dropped their price objective on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday, June 24th.

Beauty Health Trading Up 8.0%

Shares of SKIN opened at $0.71 on Thursday. The stock has a fifty day moving average price of $0.72 and a two-hundred day moving average price of $1.05. The company has a debt-to-equity ratio of 4.37, a quick ratio of 1.48 and a current ratio of 1.79. Beauty Health has a 52-week low of $0.55 and a 52-week high of $2.69. The company has a market cap of $92.35 million, a price-to-earnings ratio of -4.19 and a beta of 1.09.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The company had revenue of $64.91 million during the quarter, compared to analysts’ expectations of $66.28 million. Analysts predict that Beauty Health will post -0.14 EPS for the current fiscal year.

Institutional Trading of Beauty Health

Hedge funds have recently added to or reduced their stakes in the business. Mirabella Financial Services LLP increased its holdings in Beauty Health by 21.3% during the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after purchasing an additional 2,734,728 shares in the last quarter. Hillsdale Investment Management Inc. bought a new position in Beauty Health during the 3rd quarter worth about $293,000. Franklin Resources Inc. bought a new position in Beauty Health during the 3rd quarter worth about $31,000. Atom Investors LP bought a new position in Beauty Health during the 4th quarter worth about $29,000. Finally, Public Employees Retirement System of Ohio bought a new position in Beauty Health during the 3rd quarter worth about $26,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.